Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS1345 Category:

The global market for multimodal imaging is expected to hit USD 3.12 billion by 2024, growing from 2019 to 2024 at a CAGR of 4.46%. Growing applications of multimodal imaging systems, technological advances in the modalities of diagnostic imaging, favorable reimbursement scenario, increased insurance coverage and increased R&D in radiotracers are some of the key drivers of the market.

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 1

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 2

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 3

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 4

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 5

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 6

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 7

Multimodal Imaging Market by Technology (SPET-CT, PET-MR, PECT-CT, Trimodal, OCT), End User (Diagnostic Centers, Hospitals, Pharma-Biotech, Academia), by Application (Cardiology, Oncology, Ophthalmology, Brain, Musculoskeletal) - 2019 to 2024 8

1 Global Multimodal Imaging Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Multimodal Imaging Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Multimodal Imaging Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Multimodal Imaging Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Multimodal Imaging Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Multimodal Imaging Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Multimodal Imaging Market – By Technology (Market Size – & million/billion)
8.1 PET/CT Systems
8.2 SPECT/CT Systems
8.3 PET/MR Systems
8.4 OCT/Fundus Imaging Systems
8.5 Other

9 Global Multimodal Imaging Market – By Application
9.1 Brain & Neurology
9.2 Cardiology
9.3 Oncology
9.4 Ophthalmology
9.5 Other

10 Global Multimodal Imaging Market – By End-User
10.1 Hospitals
10.2 Diagnostic Imaging Centers
10.3 Other

11 Global Multimodal Imaging Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Multimodal Imaging Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Multimodal Imaging Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Canon, Inc.
13.3 Siemens Healthineers
13.4 GE Healthcare
13.5 Heidelberg Engineering
13.6 Infraredx, Inc. (A Part of Nipro Corporation)
13.7 Spectrum Dynamics Medical
13.8 Topcon Corporation
13.9 Koninklijke Philips N.V.
13.10 Neusoft Medical Systems Co., Ltd
13.11 Mediso Medical Imaging Systems Kft
13.12 Company 11 & more

14 Global Multimodal Imaging Market – Appendix
14.1 Sources
14.2 Abbreviations